Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Elevated Dose: Replace the standard 3.2 mg (10-unit) draw with 4.8 mg (15 units) at the same phase frequency
The theoretical synergy is compelling, and it revolves around a simple concept: you can't rebuild a house without power
Also available in a stack save up to 169,00 Cell Renewal - Advancedsave 169,00 View the stack FOXO4-DRI - Selective Senescent Cell Disruption & Longevity Interferes with senescence survival pathways Restores apoptotic signaling Targets damaged cellular populations Influences inflammatory secretory phenotype Promotes removal of dysfunctional cells Studied in aging biology models Engages FOXO4-mediated pathways Supports regenerative research environments Description FOXO4-DRI is a modified peptide designed to interfere with the interaction between FOXO4 and p53 , a key protein involved in cellular stress responses
Interaction between chicken intestinal microbiota and protein digestion
While their mechanisms of action are similar, topical acetyl hexapeptide-8 does demonstrate a lower efficacy than injected Botox, but as researchers note this is to be expected.22 Similar results were found in a small 2013 study, with the total anti-wrinkle efficacy of the Argireline treatment group being 48.9% compared to 0% in the placebo group.23 However, a more recent 2023 study investigating the effects of serum containing Argireline and hyaluronic acid found the results to be not statistically significant.24 This means that more research is needed before claims that Argireline is a true alternative to Botox can be confirmed or denied
